SR33805, a Ca 2+ antagonist with length-dependent Ca 2+-sensitizing properties in cardiac myocytes

British Journal of Pharmacology

Volumn 139, Issue 1, 2003, Pages 99-108

  Cazorla, Olivier ^a   Lacampagne, Alain ^a   Fauconnier, Jeremy ^a   Vassort, Guy ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Ca 2+ antagonist; Contractile proteins; Frank Starling relation; Heart; Stretch

Indexed keywords

2 [4 [3 [N (3,4 DIMETHOXYPHENETHYL) N METHYLAMINO]PROPOXY]BENZENESULFONYL] 3 ISOPROPYL 1 METHYLINDOLE; CALCIUM CHANNEL BLOCKING AGENT; CONTRACTILE PROTEIN; FANTOFARONE; INDO 1; MYOSIN LIGHT CHAIN; CALCIUM; INDOLE DERIVATIVE; MUSCLE PROTEIN; SULFONE;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CALCIUM TRANSPORT; CELL ISOLATION; DRUG EFFECT; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; MALE; MYOFILAMENT; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOMERE; SARCOMERE LENGTH; SENSITIZATION; STARLING LAW; ANIMAL; CELL SIZE; CHEMICAL PHENOMENA; CYTOLOGY; DOSE RESPONSE; HEART CONTRACTION; HEART VENTRICLE; IN VITRO STUDY; PATCH CLAMP; PHYSIOLOGY; WISTAR RAT;

ACTION POTENTIALS; ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CELL SIZE; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART VENTRICLES; INDOLES; MALE; MUSCLE PROTEINS; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; RATS; RATS, WISTAR; SULFONES;

EID: 0038392657     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705221     Document Type: Article

References (23)

1. ANAND, S., LIU, D., CHUGH, S., PRAHASH, A., GUPTA, S., JOHN, R., POPESCU, F. & CHANDRASHEKHAR, Y. (1997). Isolated myocyte contractile function is normal in postinfarct remodeled rat heart with systolic dysfunction. Circulation, 96, 3974 - 3984.
2. ARTEAGA, G.M., PALMITER, K.A., LEIDEN, J.M. & SOLARO, R.J. (2000). Attenuation of length dependence of calcium activation in myofilaments of transgenic mouse hearts expressing slow skeletal troponin I. J. Physiol., 526, 541 - 549.
3. BRIXIUS, K., REICKE, S. & SCHWINGER, R.H. (2002). Beneficial effects of the Ca(2+) sensitizer levosimendan in human myocardium. Am. J. Physiol., 282, H131 - H137.
4. CAZORLA, O., FREIBURG, A., HELMES, M., CENTNER, T., MCNABB, M., WU, Y., TROMBITAS, K., LABEIT, S. & GRANZIER, H. (2000). Differential expression of cardiac titin isoforms and modulation of cellular stiffness. Circ. Res., 86, 59 - 67.
5. CAZORLA, O., VASSORT, G., GARNIER, D. & LE GUENNEC, J.Y. (1999). Length modulation of active force in rat cardiac myocytes: is titin the sensor?. J. Mol. Cell Cardiol., 31, 1215 - 1227.
6. CAZORLA, O., WU, Y., IRVING, T.C. & GRANZIER, H. (2001). Titin-based modulation of calcium sensitivity of active tension in mouse skinned cardiac myocytes. Circ. Res., 88, 1028 - 1035.
7. CHATELAIN, P., CLINET, M., POLSTER, P., CHRISTOPHE, B. & MANNING, A.S. (1993). In vitro characterization of a novel Ca2+ entry blocker: SR 33805. Eur. J. Pharmacol., 246, 181 - 193.
8. 2+ channel in rat heart sarcolemmal membrane. Eur. J. Pharmacol., 267, 151 - 160.
9. FUCHS, F. & SMITH, S.H. (2001). Calcium, cross-bridges, and the Frank-Starling relationship. News. Physiol. Sci., 16, 5 - 10.
10. 2+ binding. J. Mol. Cell Cardiol., 28, 1375 - 1383.
11. GANNIER, F., BERNENGO, J.C., JACQUEMOND, V. & GARNIER, D. (1993). Measurements of sarcomere dynamics simultaneously with auxotonic force in isolated cardiac cells. IEEE Trans. Biomed. Eng., 40, 1226 - 1232.
12. HAJJAR, R.J., SCHMIDT, U., HELM, P. & GWATHMEY, J.K. (1997). Ca++ sensitizers impair cardiac relaxation in failing human myocardium. J. Pharmacol. Exp. Ther., 280, 247 - 254.
13. HOLUBARSCH, C., RUF, T., GOLDSTEIN, D.J., ASHTON, R.C., NICKL, W., PIESKE, B., PIOCH, K., LUDEMANN, J., WIESNER, S., HASENFUSS, G., POSIVAL, H., JUST, H. & BURKHOFF, D. (1996). Existence of the Frank - Starling mechanism in the failing human heart. Investigations on the organ, tissue, and sarcomere levels. Circulation, 94, 683 - 689.
14. IEIRI, S., HIRANO, K., NISHIMURA, J., SUITA, S. & KANAIDE, H. (2000). Alteration of the [Ca(2+)](i) - force relationship during the vasorelaxation induced by a Ca(2+) channel blocker SR33805 in the porcine coronary artery. Br. J. Pharmacol., 131, 1597 - 1606.
15. LEE, J.A. & ALLEN, D.G. (1997). Calcium sensitisers: mechanisms of action and potential usefulness as inotropes. Cardiovas. Res., 36, 10 - 20.
16. LEE, J.A., RUEGG, J.C. & ALLEN, D.G. (1989). Effects of pimobendan, a novel inotropic agent, on intracellular calcium and tension in isolated ferret ventricular muscle. Clin. Sci. (London), 76, 609 - 618.
17. POPPING, S., MRUCK, S., FISCHER, Y., KULSCH, D., IONESCU, I., KAMMERMEIER, H. & ROSE, H. (1996). Economy of contraction of cardiomyocytes as influenced by different positive inotropic interventions. Am. J. Physiol., 271, H357 - 364.
18. 2+ channel antagonists, SR33557 (fantofarone) and SR33805, on the L-type cardiac channel. Eur. J. Pharmacol., 263, 101 - 105.
19. SCHWINGER, R.H., BOHM, M., KOCH, A., SCHMIDT, U., MORANO, I., EISSNER, H.J., UBERFUHR, P., REICHART, B. & ERDMANN, E. (1994). The failing human heart is unable to use the Frank-Starling mechanism. Circ. Res., 74, 959 - 969.
20. SOLARO, R.J., GAMBASSI, G., WARSHAW, D., KELLER, M., SPURGEON, H., BEIER, N. & LAKATTA, E. (1993). Stereoselective actions of thiadiazinones on canine cardiac myocytes and myofilaments. Circ. Res., 73, 981 - 990.
21. VANNIER, C., LAKOMKINE, V. & VASSORT, G. (1997). Tension response of the cardiotonic agent (+)-EMD-57033 at the single cell level. Am. J. Physiol., 272, C1586 - C1593.
22. VENTURA-CLAPIER, R., MEKHFI, H. & VASSORT, G. (1987). Role of creatine kinase in force development in chemically skinned rat cardiac muscle. J. Gen. Physiol., 89, 815 - 837.
23. YAMASAKI, R., WU, Y., MCNABB, M., GREASER, M., LABEIT, S. & GRANZIER, H. (2002). Protein kinase A phosphorylates titin's cardiac-specific N2B domain and reduces passive tension in rat cardiac myocytes. Circ. Res., 90, 1181 - 1188.